Akebia Therapeutics Inc Conference Call and Live Webcast to Discuss the PRO(2)TECT Data Transcript

Sep 03, 2020 / 12:30PM GMT
Operator

Welcome to Akebia Therapeutics PRO2TECT top line data readout call. As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Kristen Sheppard.

Kristen K. Sheppard - Akebia Therapeutics, Inc. - VP of IR

Thank you, and good morning. My name is Kristen Sheppard, Senior Vice President of Investor Relations of Akebia. Thank you for joining us to discuss Akebia's top line data from PRO2TECT, the second of our 2 global Phase III cardiovascular outcomes program, evaluating vadadustat for the treatment of anemia due to chronic kidney disease.

We issued a press release containing this top line data this morning. It is also available on our Investor Relations website, along with the slides for today's call. For your convenience, an audio replay of today's call and the slides will also be available on our website shortly after we conclude today's webcast.

Joining our call today are John Butler, our President and Chief Executive Officer, and Dr. Steven Burke, our Chief Medical Officer.

Before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot